Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Filiaciones

Schwarz M:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Torre D:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Lozano-Ojalvo D:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Tan AT:

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore

Tabaglio T:

Institute of Molecular and Cell Biology, IMCB, A*STAR, Singapore, Singapore

Mzoughi S:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Sanchez-Tarjuelo R:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

Le Bert N:

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore

Lim JME:

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore

Hatem S:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Tuballes K:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Camara C:

Department of Immunology, University Hospital La Paz-IdiPAZ, Madrid, Spain

Lopez-Granados E:

Department of Immunology, University Hospital La Paz-IdiPAZ, Madrid, Spain

Paz-Artal E:

Department of Immunology, Research Institution, Sanitaria Hospital, Madrid, Spain

Department of Immunology, Ophthalmology and ENT, Complutense University of Madrid, Madrid, Spain

CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain

Correa-Rocha R:

Laboratory of Immune-Regulation, Research Institute Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Ortiz A:

Department of Nephrology, IIS-Fundación Jimenez Díaz, Madrid, Spain

Lopez-Hoyos M:

Instituto de Investigación. Department of Immunology, Hospital University of Marqués de Valdecilla-IDIVAL, Santander, Spain

Portoles J:

Department of Nephrology, Hospital of Puerta de Hierro, Madrid, Spain

Cervera I:

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

Gonzalez-Perez M:

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

Bodega-Mayor I:

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

Conde P:

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

Oteo-Iglesias J:

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain

CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain

Borobia AM:

Clinical Pharmacology, University Hospital La Paz-IDIPAZ, Platform of Clinical Research Units and Clinical Trials, Spain Faculty of Medicine Autonomous University of Madrid, Madrid, Spain

Carcas AJ:

Clinical Pharmacology, University Hospital La Paz-IDIPAZ, Platform of Clinical Research Units and Clinical Trials, Spain Faculty of Medicine Autonomous University of Madrid, Madrid, Spain

Frías J:

Clinical Pharmacology, University Hospital La Paz-IDIPAZ, Platform of Clinical Research Units and Clinical Trials, Spain Faculty of Medicine Autonomous University of Madrid, Madrid, Spain

Belda-Iniesta C:

Carlos III Health Institute, Madrid, Spain

Ho JSY:

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Nunez K:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Hekmaty S:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Mohammed K:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Marsiglia WM:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Carreño JM:

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Dar AC:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Berin C:

Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Nicoletti G:

Hyris Limited, London, UK

Della Noce I:

Hyris Limited, London, UK

Colombo L:

Hyris Limited, London, UK

Lapucci C:

Genetic Unit, Synlab Italia, Castenedolo, Italy

Santoro G:

Genetic Unit, Synlab Italia, Castenedolo, Italy

Ferrari M:

IRCCS, SDN, Napoli, Italy

Nie K:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Patel M:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Barcessat V:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Gnjatic S:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Harris J:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Sebra R:

Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Sema4, a Mount Sinai venture, Stamford, CT, USA

Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Merad M:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Krammer F:

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Kim-Schulze S:

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Marazzi I:

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Bertoletti A:

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.

Ochando J:

Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

National Center for Microbiology, Carlos III Health Institute, Madrid, Spain.

Guccione E:

Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Bioinformatics for Next Generation Sequencing (BiNGS) Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.